Publication
Article
Pharmacy Times
Generic Product News
Amoxicillin Tablets
Marketed by:
Greenstone LLC(Peapack, NJ)
Compared to:
Amoxil (GlaxoSmithKline)
Indication:
December 11, 2008—Greenstone, Pfizer's genericpharmaceutical subsidiary, announced that it introducedamoxicillin tablets in the 875-mg strength. Thetablets are indicated in the treatment of infectionsdue to susceptible strains of designated microorganismsin the following conditions: infections of theears, nose, and throat; infections of the genitourinarytract; infections of the skin and skin structure; infectionsof the lower respiratory tract; gonorrhea, acuteuncomplicated; and Helicobacter pylori eradication toreduce the risk of duodenal ulcer recurrence.
Dosage Form:
Tablets: 875 mg
For More Information:
Galantamine HydrobromideExtended-Release Capsules
Marketed by:
Watson Pharmaceuticals Inc (Corona, CA)
Compared to:
Razadyne ER(Ortho-McNeil-Janssen)
Indication:
December 16, 2008—Watson Pharmaceuticalsannounced that its subsidiary, Watson LaboratoriesInc, received FDA approval for its abbreviated newdrug application for galantamine hydrobromideextended-release capsules, eq to 8, 16, and 24 mg(galantamine base). These capsules are indicated forthe treatment of mild-to-moderate dementia of theAlzheimer's type. Galantamine hydrobromide is areversible, competitive acetylcholinesterase inhibitor.The recommended starting dose is 8 mg/day. Thedose should be increased to the initial maintenancedose of 16 mg/day after a minimum of 4 weeks—a further increase to 24 mg/day should then beattempted.
Dosage Form:
Capsules: 8, 16, and 24 mg
For More Information:
Pravastatin Sodium Tablets USP,80 mg
Marketed by:
Teva Pharmaceuticals(North Wales, PA)
Compared to:
Pravachol Tablets(ER Squibb & Sons)
Indication:
September 29, 2008—Teva Pharmaceuticalsannounced the introduction and availability ofPravastatin Sodium Tablets USP, 80 mg. With this newstrength, Teva now offers the tablets in 10-, 20-, 40-,and 80-mg strengths. Therapy with pravastatin sodiumtablets should be considered in those individuals atincreased risk for atherosclerosis-related clinical eventsas a function of cholesterol level, the presence orabsence or coronary heart disease, and other risk factors.It is one of a class of lipid-lowering compounds,the HMG-CoA reductase inhibitors, which reduce cholesterolbiosynthesis.
Dosage Form:
Tablets: 10, 20, 40, and 80 mg
For More Information:
888-TEVA USA (888-838-2872)
Sumatriptan Succinate Injection
Marketed by:
Par PharmaceuticalCompanies Inc(Woodcliff Lake, NJ)
Compared to:
Imitrex injection(GlaxoSmithKline)
Indication:
November 6, 2008—ParPharmaceutical announcedthat it will begin shipmentof Sumatriptan SuccinateInjection 4- and 6-mg starterkits and 4- and 6-mg prefilledsyringe cartridges.Sumatriptan Succinate Injection is indicated for (1) theacute treatment of migraine attacks with or withoutaura and (2) the acute treatment of cluster headacheepisodes. It is not for use in the management ofhemiplegic or basilar migraine.
Dosage Form:
Injection: 4- and 6-mg starter kits and 4- and 6-mgprefilled syringe cartridges
For More Information:
